AstraZeneca Beats Market Expectations in
Photo: Fredrik Sandberg/TT

AstraZeneca Beats Market Expectations in the Third Quarter as Revenue Reaches $16.2 Billion

Pharmaceutical giant AstraZeneca exceeds market expectations in the third quarter.

Advertisement

The company reported core earnings per share of $2.79, beating expectations of $2.62, according to Bloomberg.

Revenue came in at $16.2 billion, compared with expectations of $15.98 billion.

“With several potential blockbusters in late-stage development and transformative technologies rapidly scaling up, we are well positioned to deliver on our 2030 ambition and sustain growth over the next decade,” AstraZeneca CEO Pascal Soriot writes in the report.

In this story
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Business

All